CV: Mireille Broeders was born in 1970 in ... - Kreftregisteret

Dr. M.J.M. (Mireille) Broeders, peer-reviewed publications
Asadzadeh Vostakolaei F, Broeders M, Rostami N, van Dijck JAAM, Feuth TB, Kiemeney LALM, Verbeek ALM.
Age at diagnosis and breast cancer survival in Iran. Int J Breast Cancer 2012;2012:517976. Doi:
10.1155/2012/517976. .
Van de Wetering G, Woertman WH, Verbeek AL, Broeders MJ, Adang EMM. Quantifying short run costeffectiveness
during a gradual implementation process. Eur J Health Econ 2012, Oct 27 [Epub ahead of print].
EUROSCREEN working group [review co-ordinators: Paci E, Broeders M, Hofvind S, Duffy SW]. Summary of the
evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm
balance sheet. J Med Screen 2012;19 Suppl 1:15-13.
Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E, for the
EUROSCREEN Working Group. The impact of mammographic screening on breast cancer mortality in Europe: a
review of observational studies. J Med Screen 2012;19 Suppl 1:14-25.
Moss SM, Nyström L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M, for the EUROSCREEN Working Group. J
Med Screen 2012;19 Suppl 1:26-32.
Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E, and the EUROSCREEN Working Group. Breast
cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med
Screen 2012;19 Suppl 1:33-41.
Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S, for the EUNICE
and EUROSCREEN Working Groups. False-positive results in mammographic screening for breast cancer in
Europe: a literature review and survey of service screening programmes. J Med Screen 2012;19 Suppl 1:57-66.
Bluekens AM, Holland R, Karssemeijer N, Broeders MJ, den Heeten GJ. Comparison of digital screening
mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology
2012;265:707-14.
Asadzadeh Vostakolaei F, Broeders MJ, Mousavi SM, Kiemeney LA, Verbeek AL. The effect of demographic and
lifestyle changes on the burden of breast cancer in Iranian women: A projection to 2030. Breast 2012, July 25
[Epub ahead of print].
van Schoor G, den Heeten GJ, Broeders MJ, Verbeek Al. Improving mammographic screening test sensitivity. J
Med Screen 2012;19:105-6.
Timmers JM, van Doorne-Nagtegaal HJ, Zonderland HM, van Tinteren H, Visser O, Verbeek ALM, den Heeten
GJ, Broeders MJM. The Breast Imaging and Reporting and Data System (BI-RADS) in the Dutch breast cancer
screening programme: its role as an assessment and stratification tool. Eur Radiol 2012;22:1717-23.
van Schoor G, Otten JD, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL. Breast cancer among women over
75 years: an important public health problem? Eur J Public Health 2012;22:422-4.
Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerinck-Verheij JC, Otten JD, Broeders MJ, de Koning HJ; for the
National Evaluation Team for Breast Cancer Screening. Mammography screening and risk of breast cancer
death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73.
Visser R, Veldkamp WJH, Beijerink D, Bun PAM, Deurenberg J, Imhof-Tas MW, Schuur KH, Snoeren MM, den
Heeten GJ, Karssemeijer N, Broeders MJM. Increase in perceived case suspiciousness due to local contrast
optimisation in digital screening mammography. Eur Rad 2012;22:908-14.
Van Breest Smallenburg V, Duijm LEM, den Heeten GJ, Groenewoud JH, Jansen FH, Fracheboud J, Plaisier ML,
van Doorne-Nagtegaal HJ, Broeders MJM. Two-view versus single-view mammography at subsequent screening
in a region of the Dutch breast screening programme. Eur J Radiol 2012;81:2189-94.

Timmers JMH, van Doorne-Nagtegaal HJ, Verbeek ALM, den Heeten GJ, Broeders MJM. A dedicated BI-RADS
training programme: effect on the inter-observer variation among screening radiologists. Eur J Radiol
2012;81:2148-8.
Timmers JM, den Heeten GJ, Adang EM, Otten JD, Verbeek AL, Broeders MJ. Dutch digital breast cancer
screening: implications for breast cancer care. Eur J Public Health 2012;22:925-9.
Asadzadeh Vostakolaei F, Broeders MJ, Kiemeney LA, Verbeek AL. Opportunity for breast cancer screening: a
literature review and implications for Iran. Asian Pac J Cancer Prev 2011;12:2467-75.
Paap E, Verbeek ALM, Puliti D, Broeders MJM, Paci E. Minor influence of self-selection bias on the effectiveness
of breast cancer screening in case-control studies in the Netherlands. J Med Screen 2011;18:142-6.
Verbeek AL, Broeders MJ, van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R.
Reply: Flawed methods explain the effect of mammography screening in Nijmegen. Br J Cancer 2011;105:594-5.
de Gelder R, Fracheboud J, Heijnsdijk EA, den Heeten G, Broeders MJ, Draisma G, de Koning HJ. Digital
mammography screening: weighing reduced mortality against increased overdiagnosis. Prev Medicine
2011;53:134-40.
van Schoor G, Paap E, Broeders MJ, Verbeek AL. Residual confounding after adjustment for age: a minor issue
in breast cancer screening effectiveness. Eur J Epidemiol 2011;26:585-8.
van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL.
Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104:910-4.
Paap E, Verbeek ALM, Puliti D, Paci E, Broeders MJM. Breast cancer screening case-control study design: impact
on breast cancer mortality. Ann Oncol 2011:22:863-9.
van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL.
Effective biennial mammographic screening in women aged 40-49. Eur J Cancer 2010;46:3137-40.
Paap E, Holland R, den Heeten GJ, van Schoor G, Botterweck AA, Verbeek AL, Broeders MJ. A remarkable
reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes
Control 2010;21:1569-73.
Cox B, Ballard-Barbash R, Broeders M, Dowling E, Malila N, Shumak R, Taplin S, Buist B, Miglioretti D, for the
International Cancer Screening Network. Recording of hormone therapy and breast density in breast screening
programs: summary and recommendations of the International Cancer Screening Network. Breast Cancer Res
Treat 2010;124:793-800.
Verbeek AL, Broeders MJ. Evaluation of cancer service screening: case referent studies recommended. Stat
Methods Med Res 2010;19:487-505.
Bluekens AM, Karssemeijer N, Beijerinck D, Deurenberg JJM, van Engen RE, Broeders MJM, den Heeten GJ.
Consequences of digital mammography in population-based breast cancer screening: initial changes and long
term impact on referral rates. Eur Rad 2010;20:2067-73.
Otten JDM, Broeders MJM, den Heeten GJ, Holland R, Fracheboud J, de Koning HJ, Verbeek ALM. Life
expectancy of screen detected invasive breast cancer patients compared to women invited to the Nijmegen
screening program. Cancer 2010;116:586-91.
Bouwman R, Young K, Lazzari B, Ravaglia V, Broeders M, van Engen R. An alternative method for noise analysis
using pixel variance as part of quality control procedures on digital mammography systems. Phys Med Biol
2009;54:6809-22.

Karssemeijer N, Bluekens AM, Beijerinck D, Deurenberg JJ, Beekman M, Visser R, van Engen R, Bartels-Kortland
A, Broeders MJ. Breast cancer screening results 5 years after introduction of digital mammography in a
population-based screening program. Radiology 2009;253:353-8.
Lemmers O, Broeders M, Verbeek A, den Heeten G, Holland R, Borm GF. League tables of breast screening
units: worst-case and best-case scenario ratings helped in exposing real differences between performance
ratings. J Med Screen 2009;16:67-72.
Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL. Impressive time-related influence of
the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer
2008;123:1929-34.
Paap E, Broeders MJ, van Schoor G, Otten JD, Verbeek AL. Large increase in a Dutch woman’s lifetime risk of
developing breast cancer. Eur J Cancer 2008;44:1485-7. Epub 2008 May 12.
van Schoor G, Broeders MJ, Paap E, Otten JD, den Heeten GJ, Verbeek AL. A rationale for starting screening
under age 50. Ann Oncol 2008;19:1208-9. Epub 2008 Apr 29.
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance
in breast cancer screening and diagnosis. Fourth edition – summary document. Ann Oncol 2008;19:614-622.
Kiemeney LA, Broeders MJ, Pelger M, Kil PJ, Schröder FH, Witjes JA, Vasen HF. Screening for prostate cancer in
Dutch hereditary prostate cancer families. Int J Cancer 2008;122:871-876.
Broeders MJM, Verbeek ALM. Mammographic screening is only relevant in the preclinical detectable period of
breast cancer [Letter]. J Med Screen 2005;12:107.
Broeders MJM, Scharpantgen A, Ascunce N, Gairard B, Olsen A-H, Mantellini P, Cerdá Mota T, Van Limbergen E,
Séradour B, Ponti A, Salas Trejo L, Nyström L, for the European Breast Cancer Network (EBCN). Comparison of
early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000.
Eur J Cancer Prev 2005;14:107-116.
Fracheboud J, Otto SJ, Dijck JAAM van, Broeders MJM, Verbeek ALM, Koning HJ de, and National Evaluation
Team for Breast cancer screening (NETB). Decreased rates of advanced breast cancer due to mammography
screening in The Netherlands. Br J Cancer 2004;91:861-867.
Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JHCL, Verbeek ALM, de Koning HJ, and
the National Evaluation Team for Breast Cancer Screening. Initiation of population-based mammography
screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet
2003;361:1411-1417.
Broeders MJM, Onland-Moret NC, Rijken HJTM, Hendriks JHCL, Verbeek ALM, Holland R. Use of previous
screening mammograms to identify features indicating cases that would have a possible gain in prognosis
following earlier detection. Eur J Cancer 2003;39:1770-1775.
Verbeek ALM, Broeders MJM. Evaluation of The Netherlands breast cancer screening programme. Ann Oncol
2003:14:1203-1205.
Broeders MJM, Verbeek ALM, Straatman H, Peer PGM, Pasker-de Jong PCM, Beex LVAM, Hendriks JHCL,
Holland R. Repeated mammographic screening reduces breast cancer mortality along the continuum of age. J
Med Screen 2002;9:163-167.
Fracheboud J, Koning HJ de, Boer R, Groenewoud JH, Verbeek ALM, Broeders MJM, Ineveld BM van, Hendriks
JHCL, Bruyn AE de, Holland R, Maas PJ van der. Nationwide breast cancer screening programme fully
implemented in the Netherlands. Breast 2001;10:6-11.

Broeders MJM, Peer PGM, Straatman H, Beex LVAM, Hendriks JHCL, Holland R, Verbeek ALM. Diverging breast
cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands,
1969-1997. Int J Cancer 2001;92:303-308.
Klabunde CN, Sancho-Garnier H, Broeders M, Thoresen S., Rodrigues VJL, Ballard-Barbash R. Quality assurance
for screening mammography data collection systems in 22 countries. Int J Technol Assess Health Care
2001;17(4):528-541.
Ballard-Barbash R, Klabunde C, Paci E, Broeders M, Coleman EA, Fracheboud J, Bouchard F, Rennert G, Shapiro
S, for the International Breast Screening Network. Breast cancer screening in 21 countries: delivery of services,
notification of results and outcomes ascertainment. Eur J Cancer Prev 1999;8:417-426.
Fracheboud J, Koning HJ de, Beemsterboer PMM, Boer R, Verbeek ALM, Hendriks JHCL, Ineveld BM van,
Broeders MJM, Bruyn AE de, Maas PJ van der. Interval cancers in the Dutch breast cancer screening
programme. Br J Cancer 1999;81(5):912-917.
Shapiro S, Coleman EA, Broeders MJM, Codd M, Koning HJ de, Fracheboud J, Moss S, Paci E, Stachenko S,
Ballard-Barbash R, for the International Breast Screening Network (IBSN) and the European Network of Pilot
Projects for Breast Cancer Screening. Breast cancer screening programmes in 22 countries: current policies,
administration and guidelines. Int J Epidemiol 1998;27:735-742.
Broeders MJM, Verbeek ALM. Breast cancer epidemiology and risk factors. Q J Nucl Med 1997;41(3):179-88.
Dijck JAAM van, Broeders MJM, Verbeek ALM. Mammographic screening. Benefits for older women. Med
Progress 1997;24:10-13.
Dijck JAAM van, Broeders MJM, Verbeek ALM. Mammographic screening in older women. Is it worthwhile?
Drugs Aging 1997;10(2):69-79.
Murphy MFG, Broeders MJM, Carpenter LM, Gunnarskog J, Leon DA. Breast cancer risk in mothers of twins. Br J
Cancer 1997;75(7):1066-68.
Broeders MJM, Lambe M, Baron JA, Leon DA. History of childbearing and colorectal cancer risk in women aged
less than 60: an analysis of Swedish routine registry data 1960-84. Int J Cancer 1996;66:170-5.
Leon DA, Carpenter LM, Broeders MJM, Gunnarskog J, Murphy MFG. Breast cancer in Swedish women before
age 50; evidence of a dual effect of completed pregnancy. Cancer Causes Control 1995;6:283-91.